Onconic Therapeutics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	29,425	14,838	21,056	95	60
Revenue Growth (YoY)	442.96%	-29.53%	22064.25%	58.33%	-
Cost of Revenue	60.97	3.78	2.37	14,933	8,402
Gross Profit	29,364	14,835	21,054	-14,838	-8,342
Selling, General & Admin	17,857	8,087	2,463	-	-
Research & Development	9,192	10,929	15,761	-	-
Other Operating Expenses	134.43	164.15	138.3	-	-
Operating Expenses	27,657	19,632	18,823	-	-
Operating Income	1,707	-4,798	2,231	-14,838	-8,342
Interest Expense	-7,460	-664.16	-1,776	-1,078	-6,831
Interest & Investment Income	1,204	942.63	863.01	1,431	18.85
Currency Exchange Gain (Loss)	-2,597	2,020	-79.65	-	-
Other Non Operating Income (Expenses)	9,465	-7,442	-576.09	52.86	5.74
EBT Excluding Unusual Items	2,319	-9,942	662.51	-14,432	-15,149
Gain (Loss) on Sale of Assets	-	-	-0.7	-	-
Pretax Income	2,319	-9,942	661.81	-14,432	-15,149
Income Tax Expense	-2,253	-1,849	-1,021	-	-
Net Income	4,572	-8,093	1,682	-14,432	-15,149
Net Income to Common	4,572	-8,093	1,682	-14,432	-15,149
Shares Outstanding (Basic)	14	11	1	8	8
Shares Outstanding (Diluted)	14	11	1	8	8
Shares Change (YoY)	778.57%	1314.60%	-90.00%	0.94%	-
EPS (Basic)	337.89	-742.36	2183.25	-1872.68	-1984.20
EPS (Diluted)	333.39	-742.36	2183.25	-1872.68	-1984.20
Free Cash Flow	-4,239	-7,982	2,983	-17,536	-8,861
Free Cash Flow Per Share	-309.01	-732.23	3870.30	-2275.46	-1160.69
Gross Margin	99.79%	99.98%	99.99%	-	-
Operating Margin	5.80%	-32.33%	10.60%	-15618.48%	-13903.24%
Profit Margin	15.54%	-54.54%	7.99%	-15191.48%	-25247.72%
Free Cash Flow Margin	-14.41%	-53.79%	14.16%	-18458.96%	-14769.11%
EBITDA	2,032	-4,345	2,691	-14,770	-8,292
EBITDA Margin	6.91%	-29.28%	12.78%	-	-
D&A For EBITDA	324.45	452.67	460.13	67.43	49.65
EBIT	1,707	-4,798	2,231	-14,838	-8,342
EBIT Margin	5.80%	-32.33%	10.60%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.